Genotyping og human papillomavirush in a population of women with an active sex life sex from an EPS in Barranquilla between January and December of 2011
Keywords:
High-risk lesion, Human Papilloma Virus, Cervical cancerAbstract
Background: In Colombia, cervical cancer is the most common type of cancer among women and is the second leading cause death by cancer. In the last five years there have been between 490,000 and 500,000 new cases of female carriers of the Human Papilloma Virus, of which between 300,000 and 220,000 will evolve to become cervical cancer and around 243,000 will end in death. A number of studies have shown the fundamental role of viral genotype in the evolution of cervical cancer. Objective: To genotype the human papillomavirus in a population of sexually active female affiliates of a health promotion entity in Barranquilla between the months of January and December of 2011. Materials and Methods: A cross-sectional study with multiple variables, using as a source of 100 samples of epithelial tissue product of biopsies from patients whose cytology and colposcopy results were positive for high- grade neoplasms. Results: Of the 100 samples where the existence of the virus was confirmed, 45 were of genotype HPV 16, 28 of HPV genotype 18, 10 HPV genotype 33 and it was less frequently found the HPV 6, 11, 26, 31, 35, 39, 42, 45, 54, 58, 59 and 66, which are recorded in the Caribbean Region especially in Barranquilla. Conclusion: The genotypes found with greater frequency in the sample are HPV 16 and 18, while the ones with lower frequency correspond to others that have previously been reported in the region.
Downloads
References
2.IARC, Screening Group. Cervical Cancer Screening Activities Directory [libro en Inter- net]. France: IARC; 2008 [citado 10 febrero 2012]. Disponible en: http://screening.iarc. fr/activ/activityintroduction.php
3.Piñeros M, Ferlay J. Incidencia estimada de Cáncer en Colombia a nivel departamental y nacional. Salud Pública. 2006; 6:1-20.
4.Murillo R, Quintero A, Piñeros M, Bravo MM, Cendales R, Wiesner C, et al. Modelo para el control del cáncer en Colombia. Serie docu- mentos técnicos INC. 2006; 1(1):1-20.
5.Van Regenmortel MHV. Virus taxonomy: se- venth report of the international committee on Taxonomy of virus. California: Academic Press; 1999.
6.Campos R, Melo V, Del Castilho D, Castro P. Prevalência do papilomavirus humano e seus genótipos em mulheres portadoras e não portadoras do vírus da imunodeficiência humana. Revista Brasileira de Ginecologia e Obstetrícia. 2005; 5:248-56.
7.Fausch SC, Da Silva DM, Rudolf MP, Kast WM. Human papillomavirus virus-like particles do not activate langerhans cells: a possible im- mune escape mechanism used The Journal of Immunology. 2002; 169:32424-9.
8.Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Res Cancer. 2002; 2(5):342-50.
9.Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavi- rus genotype distribution in low-grade cervi- cal lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev. 2005b; 14:1157-64.
10.Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemio- logic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348:518-527.
11.Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. Classification of papillo- maviruses. Virology. 2004; 324:17-27.
12.Münger K, Baldwind KM, Hayakawa H, Ngu- yen C, Owens M, Grace M, et al. Mechanisms of Human Papillomavirus-Induced Oncogé- nesis. Journal of Virology. 2004:11451-11460.
13.Peck Sabater A, Kiviat NB. Detección y clasi- ficación de la neoplasia cervical en la era del VPH. 2010.
14. Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005; 32(SuppI1):S7-S15.
15.Halfon P, Trepo E, Antoniotti G, Bernot C, Cart-Lamy P, Khiri H et al. Prospective Evalua- tions of the Hybrid Capture 2 and AMPLICOR Human Papillomavirus (HPV) Test for detec- tion of 13 High-Risk HPV Genotypes in atypi- cal squamous cells of uncertain significance. J. Clin Microbiol. 2007; 45:313-316.
16.Levi G, Feldman J, Holman S, Salarieh A, Stric- kler H, Alter S et al. Relationship between HIV viral load and Langerhans cells of the cervical epithelium. The Journal of Obstetrics and Gynaecology Research. 2005; 178-184.
17.McMurray HR, Nguyen TF, Westbrook D, Mc- Cance J. Biology of Human papillomaviruses. International Journal of Experimental Patho- logy. 2001; 82:15-33.
18.McLaughlin-Drubin ME, Huh KW, Münger K. The Human Papillomavirus Type 16 E7 Onco- protein Associates with E2F6. Journal of Viro- logy. 2008; 82 (17):8695-8705.
19.Steben M, Duarte-Franco E. Human Papillo- mavirus infection: Epidemiology and patho- physiology.Gynecologic Oncology. 2007; 107:S2-S5.
Downloads
Published
Issue
Section
License
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
